Editors: Editorial Board

The views & opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC. More

  • Article of the Month

    Dr. Anna Plitt reviews a comparative study of bridging therapy with heparin vs. continued warfarin therapy without a bridge in patients with moderate-to-high risk of thromboembolic events.

    More
  • Video

    Drs. Peter Block and Nikolaus Sarafoff discuss this trial comparing six weeks vs. six months clopidogrel in DES patients receiving triple therapy.

    More
  • Hot Topic

    Dr. Dylan Steen evaluates the most clinically relevant updates to the atrial fibrillation guidelines.

    More
  • Case Challenge

    A 74-year-old man presents to the emergency department with progressive shortness of breath and a history of hypertension and CAD. Which anticoagulation strategy would lead to the lowest rate of recurrent venous thromboembolism, without exposing the patient to excessive risk of clinically significant bleeding?

    More
  • Community

    Visit this community to learn more about and discuss topics related to the entire class of novel oral anticoagulants.

    More
  • Resource

    As a member of The Evolution of Anticoagulation Management – Atrial Fibrillation (TEAM-A) partnership, the ACC is pleased to share access to valuable resources.

    More

Question of the Month

advertisement

SITE SPONSORED BY

advertisement